• Info
  • Insider Ownership

Insider Trading & Ownership of Michael R. Dougherty

Location
Exton, PA
Summary
The estimated net worth of Michael R. Dougherty is at least $220,905 dollars as of 20 Jun 2023. Michael R. Dougherty is the Director of IDERA PHARMACEUTICALS, INC. and owns shares of Aceragen, Inc. stock worth about $191.3K. Michael R. Dougherty is the Director of MARINUS PHARMACEUTICALS INC and owns shares of MARINUS PHARMACEUTICALS, INC. stock worth about $29.6K.
Signature
/s/ Joel Solomon, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Michael R. Dougherty and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Michael R. Dougherty has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $220,905.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: IDERA PHARMACEUTICALS, INC. ($191,329).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Michael R. Dougherty

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IDRA IDERA PHARMACEUTICALS, INC. Director $191,329 11 Jan 2023
MRNS MARINUS PHARMACEUTICALS INC Director $29,576 04 Feb 2022
TRVN TREVENA INC Director 15 Jun 2023

Insider Transactions Reported by Michael R. Dougherty:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.